Results 31 to 40 of about 5,328 (197)

Repurposing of auranofin and honokiol as antifungals against Scedosporium species and the related fungus Lomentospora prolificans

open access: yesVirulence, 2021
The slowing-down de novo drug-discovery emphasized the importance of repurposing old drugs. This is particularly true when combating infections caused by therapy-refractory microorganisms, such as Scedosporium species and Lomentospora prolificans. Recent
Hajar Yaakoub   +6 more
doaj   +1 more source

Auranofin exerts antibacterial activity against Neisseria gonorrhoeae in a female mouse model of genital tract infection

open access: yesPLoS ONE, 2022
Neisseria gonorrhoeae has been classified by the U.S. Centers for Disease Control and Prevention as an urgent threat due to the rapid development of antibiotic resistance to currently available antibiotics.
Ahmed E. M. Elhassanny   +2 more
doaj   +2 more sources

Structural basis for the inhibitory mechanism of auranofin and gold(I) analogues against Pseudomonas aeruginosa global virulence factor regulator Vfr

open access: yesComputational and Structural Biotechnology Journal, 2023
Pseudomonas aeruginosa is a leading cause of hospital-acquired infections. Treatment of P. aeruginosa infections is difficult given its multiple virulence mechanisms, intrinsic antibiotic resistance mechanisms, and biofilm-forming ability.
Yingdan Zhang   +6 more
doaj   +1 more source

Will Auranofin Become a Golden New Treatment Against COVID-19?

open access: yesFrontiers in Immunology, 2021
Auranofin is an FDA-approved disease-modifying anti-rheumatic drug that has been used for decades for treatment of rheumatoid arthritis. This gold(I) compound has anti-inflammatory properties because it reduces IL-6 expression via inhibition of the NF-κB-
Karine Sonzogni-Desautels   +4 more
doaj   +1 more source

Auranofin-Based Analogues Are Effective Against Clear Cell Renal Carcinoma In Vivo and Display No Significant Systemic Toxicity

open access: yes, 2020
Effective pharmacological treatments for patients with advanced clear cell renal carcinoma (ccRCC) are limited. Bimetallic titanium–gold containing compounds exhibit significant cytotoxicity against ccRCC in vitro and in vivo and inhibit invasion and ...
Won Seok Yang (8728251)   +6 more
core   +1 more source

Auranofin is highly efficacious against Toxoplasma gondii in vitro and in an in vivo experimental model of acute toxoplasmosis. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2014
The mainstay of toxoplasmosis treatment targets the folate biosynthetic pathways and has not changed for the last 50 years. The activity of these chemotherapeutic agents is restricted to one lifecycle stage of Toxoplasma gondii, they have significant ...
Rosa M Andrade   +3 more
doaj   +1 more source

Auranofin, an Anti-rheumatic Gold Drug, Aggravates the Radiation-Induced Acute Intestinal Injury in Mice

open access: yesFrontiers in Pharmacology, 2019
Pelvic and abdominal radiotherapy plays an important role in eradication of malignant cells; however, it also results in slight intestinal injury.
Eun Sang Lee   +6 more
doaj   +1 more source

Auranofin and Baicalin Inhibit Clostridioides difficile Growth and Sporulation: An In vitro Study

open access: yesJournal of Pure and Applied Microbiology, 2022
Clostridioides difficile is a principal cause of hospital-acquired gastrointestinal infections, with sporulation and toxin production being key determinants in the disease pathogenesis.
Lamiaa A. Madkour
doaj   +1 more source

Auranofin Resistance in Toxoplasma gondii Decreases the Accumulation of Reactive Oxygen Species but Does Not Target Parasite Thioredoxin Reductase

open access: yesFrontiers in Cellular and Infection Microbiology, 2021
Auranofin, a reprofiled FDA-approved drug originally designed to treat rheumatoid arthritis, has emerged as a promising anti-parasitic drug. It induces the accumulation of reactive oxygen species (ROS) in parasites, including Toxoplasma gondii.
Christopher I. Ma   +10 more
doaj   +1 more source

Expression of the thioredoxin system in an in vivo-like cancer cell environment upon auranofin treatment

open access: yes, 2016
As essential elements of the tumor microenvironment, the variable oxygenation state of the tumor tissue, the extracellular matrix (ECM) and different cell types are important determinants of carcinogenesis.
Tonissen, K. F.   +22 more
core   +1 more source

Home - About - Disclaimer - Privacy